Bcn Peptides is an API manufacturer based in Spain. It holds 24 active US drug master files across a filed portfolio of 14 molecules. Its GMP standing is certified by EMA, US FDA and NCELS (KZ), among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 9 October 2023 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Barcelona, Spain | Not on file |
| Spain, Spain | 3008205509 |
| Sant Quinti De Mediona, Spain | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Vasopressin | SFDA (Saudi Arabia), US FDA | 4 |
| Desmopressin | SFDA (Saudi Arabia), US FDA | 3 |
| Leuprolide | SFDA (Saudi Arabia), US FDA | 3 |
| Octreotide | SFDA (Saudi Arabia), US FDA | 3 |
| Angiotensin Ii | US FDA | 2 |
| Cetrorelix | US FDA | 2 |
| Ganirelix | US FDA | 2 |
| Icatibant | US FDA | 2 |
| Lanreotide | US FDA | 2 |
| Nesiritide | US FDA | 2 |
| Salmon Calcitonin | US FDA | 2 |
| Tetracosactide | US FDA | 2 |
| Carbetocin | SFDA (Saudi Arabia) | 1 |
| Terlipressin | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 3 | None |
| EMA | None | 1 |
| US FDA | None | 1 |
| NCELS (KZ) | None | 1 |
| AEMPS (ES) | None | 1 |
Choose your molecules and target markets. Bcn Peptides comes back tiered against every other supplier able to file there.
Start for free